{ "item_title" : "Characterizing Biotherapeutics", "item_author" : [" Jennie R. Lill", "Wendy Sandoval "], "item_description" : "Although monoclonal antibodies comprise the largest share of approved therapeutic molecules, many new non-antibody modalities are being evaluated in the clinic. These new biologics are more complex, which comes as a result of a greater understanding of underlying disease biology as well as advanced engineering approaches. All recombinant proteins made for both research purposes and as therapeutic moieties undergo in depth analytical characterization using a variety of tools including mass spectrometry. As molecules increase in their complexity, the analytical field has had to keep up with improvements in the high-throughput, complexity, and sensitivity of characterization techniques-- Provided by publisher. ", "item_img_path" : "https://covers3.booksamillion.com/covers/bam/1/39/423/611/1394236115_b.jpg", "price_data" : { "retail_price" : "215.00", "online_price" : "215.00", "our_price" : "215.00", "club_price" : "215.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }

Overview

Customers Also Bought

Details